| Poster | Poster Session 09 Program Schedule
02/16/2024
03:30 pm - 04:45 pm
Room: Shubert Complex (Posters 1-60)
Poster Session 09: Epilepsy | Oncology | MS | Infectious Disease
Final Abstract #41
BMI and Psychological Health in Long Covid-19 Patients: An Exploration of Cognitive Function, Anxiety, Depression, Apaty, Fatigue and General Health Status.
Carmen García-Sánchez, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Marco Calabria, Univeristat Oberta de Catalunya, Barcelona, Spain
Nicholas Grunden, Department of psychology, Concordia University., Montreal, Canada
Juan Antonio Arroyo, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Marina del Carmen Estevez Garcia, Facultad de Medicina, Barcelona, Spain
Roberto Belvis, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Noemí Morollon, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Isabel Mur, Hospital de la Santa Creu i Sant Pau, Barcelona, United States
Virginia Pomar, Hospital de la Santa Creu i Sant Pau, Barcelona, United States
Pere Domingo, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Category: Infectious Disease (HIV/COVID/Hepatitis/Viruses)
Keyword 1: infectious disease
Keyword 2: cognitive functioning
Keyword 3: brain disorder
Objective:
Examining body mass index (BMI) in Long COVID-19 patients is vital to uncovering potential mechanisms through which BMI might influence cognitive symptoms and psychological well-being in this population. This understanding could reveal how BMI-associated factors like inflammation, immune response, and metabolic changes contribute to the persistence of COVID-19 symptoms.
This study aimed to investigate the potential association between body mass index (BMI) and cognitive performance, anxiety, depression, apathy, and fatigue among Long Covid-19 patients who initially reported subjective cognitive complaints. Additionally, we aimed to explore whether BMI influences the perception of general health in these patients.
Participants and Methods:
A total of 188 Long Covid-19 patients (52±12.9 years old; 14±4.83 years of education) were included in the study, divided into three groups based on their weight status: normal weight (NW) (n=79), overweight (OW) (n=73), and obesity (OB) (n=36). There were no underweight patients in the current sample. Various psychological variables were assessed, including cognitive performance (MOCA-Telephone), levels of anxiety and depression (Hospital Anxiety and Depression Scale), self-reported fatigue scores (Frontal Systems Behavior Scale, fatigue with the Modified Fatigue Scale), and general health status indicated using a 0-10 visual analog scale.
Results:
Cognitive performance, measured via the MOCA-Telephone, did not exhibit significant differences across weight status groups (NW: 17.49 ± 3.4; OW: 17.07±2.9; OB: 16.26±3.2). Similarly, there were no significant differences between the three groups in terms of anxiety (NW: 8.44 ± 5.2; OW: 9.34±4.4; OB: 9.43±5.3), depression (NW: 7.4± 4.2; OW: 7.9±4.6; OB: 7.89±4.6), apathy in T score (NW: 72.36 ± 20; OW: 77.09±18.24; OB: 80±21.8), fatigue (NW: 52.52 ± 17,8; OW: 54,5±15; OB: 53,1±20), or general health perception (NW: 5.1±1.85; OW: 5±1.23; OB: 4.38±1.97)
Conclusions:
With no evidence of significant differences in cognitive function, anxiety, depression, apathy, or perceived health status across groups of differing weight status, our results suggest that BMI may not be a direct determinant of these psychological aspects within the context of Long COVID-19.
|
|---|
